Coated medical devices comprising a water-insoluble therapeutic agent and an additive
A medical device, water-insoluble technology, applied in the field of medical substances and devices, which can solve the problems of complex, inability to deliver therapeutic agents, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0060] In a particular preparation method, an amount of a liquid coating medium as described herein is applied to the surface of an implantable structure of a medical device using a suitable application method (e.g., as discussed above), and removed The solvent, usually by evaporation, forms a TA-releasing layer on the surface. To this end, the solvent may be evaporated under any suitable conditions, including temperature conditions that may be heated, cooled, or ambient (room temperature), and / or pressures that may be atmospheric (i.e., one atmosphere), superatmospheric, or subatmospheric conditions, and / or under different humidity conditions, including reduced humidity conditions (eg, below 30%, or below 20% humidity).
[0061] In other preparation methods, the aqueous solution of the H / D additive and the organic solvent solution of the water-insoluble therapeutic agent can be applied to the surface of the implantable structure of the medical device to be coated shortly befo...
Embodiment 1
[0078] paclitaxel / heparin coated balloon catheter
[0079] Group A : 10.2 mL of water was added to 0.714 g of sodium heparin, and the mixture was placed in a vortex mixing device until the sodium heparin was dissolved. This solution was added dropwise to a solution of 6 g of paclitaxel dissolved in 500 mL of ethanol on a shaking table. The resulting solution was a 2% aqueous ethanol solution containing paclitaxel and sodium heparin in a weight ratio of about 10:1. The solution was added to a Sonotek ultrasonic coating device and spray applied to a cell with a balloon length of 4 cm and an inflated diameter of 7 mm. The outer surface of the 18LP balloon catheter inflates the angioplasty balloon. The coating nozzle was moved relative to the balloon to apply a uniform layer of a mixture of paclitaxel and heparin sodium sulfate having a weight ratio of dry solid paclitaxel:heparin sodium of about 10:1 to the balloon and the solvent was evaporated to form a solid. Continue ...
Embodiment 2
[0082] Dissolution Test of Paclitaxel / Heparin Sodium Coated Balloon Catheters
[0083] Balloon catheters prepared according to Group A in Example 1 were subjected to a paclitaxel dissolution test, compared to similarly prepared balloon catheters, which differed by having a concentration of about 3 μg / mm 2 Paclitaxel-only coating of paclitaxel. Specifically, the coated balloon of the balloon catheter was immersed in a 0.2% w / v solution of hepta(2,6-bis-O-methyl)-β-cyclodextrin under resting conditions at approximately 37°C middle. Samples of the dissolution medium were taken at different exposure times and analyzed to determine the percentage of paclitaxel initially present on the balloon that had been released. The results show faster paclitaxel release from the balloon in the catheter prepared according to Example 1 Group A. After 5 minutes of immersion at rest, the balloons prepared according to Example 1 Group A (10:1 paclitaxel:heparin sodium by weight) released an av...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com